Home
Generex Biotechnology

Generex Biotechnology Market Share Analysis for May 2026

we are committed to delivering computer service, support and repair solutions for all of your digital needs. choose from our onsite, online, or telephone support services. desktop, laptop, smartphone, tablet or netbook service or repairs onsite computer

Health > Biotechnology and Pharmaceuticals

Domaingenerex.com

Year Founded1983

Employees51 - 200

Annual Revenue$1M - $2M

Generex Biotechnology

Generex Biotechnology (including company regionals)

generex.com

See more website traffic and engagement information

Generex Biotechnology Revenue up to May 2026 is 1M - 2M

revenue generated by Generex Biotechnology top domains

Generex Biotechnology top domains revenue over 3 years

Revenue for Generex Biotechnology top domains

generex.com1M - 2M

See more with Sales Intelligence

Total visits to Generex Biotechnology's top domains

Understand Generex Biotechnology market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Generex Biotechnology's top domains

Analyze Generex Biotechnology engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Generex Biotechnology's top domains

See how Generex Biotechnology keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Generex Biotechnology top competitors by domain

Top similar sites in May 2026, ranked by their affinity

advanced-biomedical.co.ukCompany NameADVANCED BIOMEDICAL LIMITEDEmployees51 - 200HQUnited Kingdom, OldhamAnnual revenue$25M - $50MTotal visits51Health > Biotechnology and Pharmaceuticals

Top technologies used by Generex Biotechnology

These are the website technologies, by industry, used by Generex Biotechnology top domains

Conversion & Analytics (2)

Google Analytics

Widget (2)

reCAPTCHA

Audio Video Media (1)

YouTube

Mobile (1)

Meta Viewport

More Technologies

2

See all

News & Signals from Generex Biotechnology

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGenerex Biotechnology Corporation goes public.NuGenerex has filed registration for an IPO to raise $50 million.

NewsGenerex Biotechnology Corporation launches NuGenHealth SaaS program.Generex Biotechnology Corporation is excited to launch its NuGenHealth SaaS program, and Generex Biotechnology Corporation look forward to continued expansion of its RPM business with the announcement of additional contracts in the next several weeks.”

NewsGenerex Biotechnology Corporation is developing peptide vaccines for cancer and infectious disease based on Ii-Key.Nugenerex is developing peptide vaccines for cancer and infectious disease based on Ii-Key, its CD4 T-cell activation platform.